New Anti-Tuberculosis Drugs in Clinical Development: An Overview

E-ISSN： 1875-6646|5|2|137-154

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.5, Iss.2, 2009-06, pp. : 137-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overview of Anti-Tuberculosis (TB) Drugs and Their Resistance Mechanisms

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1177-1185

Bentham Science Publishers

Access to resources Recommend Favorite

New Anti-Tuberculosis Drugs with Novel Mechanisms of Action

Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-01 ,pp. : 1956-1967

Bentham Science Publishers

Access to resources Recommend Favorite

New Anti-Tuberculosis Drugs: Strategies, Sources and New Molecules

Current Medicinal Chemistry, Vol. 16, Iss. 15, 2009-05 ,pp. : 1898-1904

Bentham Science Publishers

Access to resources Recommend Favorite

DFT Based QSAR/QSPR Models in the Development of Novel Anti-tuberculosis Drugs Targeting Mycobacterium tuberculosis

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4455-4473

Bentham Science Publishers

Access to resources Recommend Favorite

New Tuberculosis Drugs in Development

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 463-473

Bentham Science Publishers

Access to resources Recommend Favorite